From: Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit
Total (n = 248)
Survivors < 4 years (n = 188)
Long-term survivors (≥ 4 years) (n = 60)
Number of lines of treatment
1
39 (16%)
34 (18%)
5 (8%)
2
63 (25%)
51 (27%)
12 (20%)
3
67 (27%)
52 (28%)
15 (25%)
4
79 (32%)
28 (47%)